Pharmacologic Treatment for High BP and Risk of CVD

To the Editor A recent meta-analysis of randomized trials of pharmacologic treatment for high blood pressure (BP) reported that antihypertensive therapy reduced the risk of cardiovascular disease (CVD) and mortality similarly in patients with and without orthostatic hypotension. The authors therefore advocated for intensive antihypertensive treatment despite the presence of orthostatic hypotension.
Source: JAMA - Category: General Medicine Source Type: research